Barfield Elaine, Deshmukh Farah, Slighton Elisabeth, Lentine Jennifer, Lu Yao, Ma Xiaoyue, Christos Paul J, Sockolow Robbyn E, Loughlin Gerald, Pillai Sophia
NewYork-Presbyterian Weill Cornell Medicine, New York, NY, USA.
Mayo Clinic, Rochester, MN, USA.
Clin Pediatr (Phila). 2020 Jun;59(6):573-579. doi: 10.1177/0009922820910821. Epub 2020 Mar 7.
. The available literature on pulmonary disease in pediatric inflammatory bowel disease is limited. We evaluated the prevalence of pulmonary manifestations in pediatric inflammatory bowel disease and their association with disease severity. . Patients completed the St. George's Respiratory Questionnaire (SGRQ), a self-reported measure of quality of life in patients with pulmonary disease. Chart review provided demographic information and Pediatric Crohn's Disease Activity Index (PCDAI) and Pediatric Ulcerative Colitis Activity Index scores. Regression models were utilized to evaluate associations between SGRQ score and clinical risk factors. . The prevalence of pulmonary manifestations was 9.62% (95% confidence interval = 5.48% to -15.36%). PCDAI scores in Crohn's disease patients with pulmonary symptoms were significantly higher (SGRQ mean = 10.71 ± 10.94) than in patients without such symptoms. SGRQ score was also higher in patients with indeterminate colitis (8.64, 95% confidence interval = 0.72-16.57, = .03), when compared with Crohn's disease. . Additional investigations including pulmonary function tests and imaging could provide further insight into this issue.
关于小儿炎症性肠病肺部疾病的现有文献有限。我们评估了小儿炎症性肠病肺部表现的患病率及其与疾病严重程度的关联。患者完成了圣乔治呼吸问卷(SGRQ),这是一种对肺部疾病患者生活质量的自我报告测量方法。病历审查提供了人口统计学信息以及儿童克罗恩病活动指数(PCDAI)和儿童溃疡性结肠炎活动指数评分。使用回归模型评估SGRQ评分与临床风险因素之间的关联。肺部表现的患病率为9.62%(95%置信区间=5.48%至15.36%)。有肺部症状的克罗恩病患者的PCDAI评分显著高于(SGRQ平均值=10.71±10.94)无此类症状的患者。与克罗恩病相比,不确定结肠炎患者的SGRQ评分也更高(8.64,95%置信区间=0.72 - 16.57,P =.03)。包括肺功能测试和影像学在内的进一步调查可以提供对这个问题的进一步见解。